Ribosome-associated proteins that bind to the 5'NTR of HAV vary substantially among different mammalian cell types, possibly accounting for differences in viral growth support.
No takes yet. Share an insight, caveat, or question.
Cell-type differences in HAV-binding proteins should not alter clinical practice; leaves open their role as host determinants of viral permissiveness.
Chang et al. (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: